Tigecycline Does Not Prolong Corrected QT Intervals in Healthy Subjects

We evaluated the effect of tigecycline (50-mg and 200-mg doses) on corrected QT (QTc) intervals and assessed safety and tolerability in a randomized, placebo-controlled, four-period crossover study of 48 (44 male) healthy volunteers aged 22 to 53 years. Fed subjects received tigecycline (50 mg or 20...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Korth-Bradley, Joan M., McGovern, Paul C., Salageanu, Joanne, Matschke, Kyle, Plotka, Anna, Pawlak, Sylvester
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3623319/
https://ncbi.nlm.nih.gov/pubmed/23403419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01576-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados